de Winter, Derek P.
Kaminski, Allysen
Tjoa, May Lee
Oepkes, Dick
Article History
Received: 20 September 2022
Accepted: 21 December 2022
First Online: 7 January 2023
Declarations
:
: Not applicable.
: Not applicable.
: Derek P. de Winter: PhD program funded by Momenta Pharmaceuticals, Inc., which was acquired by Johnson & Johnson; coordinating investigator for a phase 2 trial (NCT03842189) of a new drug for the treatment of HDFN, which is sponsored by Janssen Pharmaceuticals.Allysen Kaminski: Former employee of OPEN Health, which was retained by Janssen Pharmaceuticals to conduct the study.May Lee Tjoa: Employee and stockholder of Janssen Pharmaceuticals.Dick Oepkes: Former principal investigator for a phase 2 trial (NCT03842189) of a new drug for the treatment of HDFN, which is sponsored by Janssen Pharmaceuticals.